Wernicke encephalopathy in people who do not drink alcohol is being reported after a wide range of gastrointestinal operations, and most of those patients do not present with the textbook signs, according to a systematic review published on 30 June 2026 in Frontiers in Surgery. The review, by Hala Abu-Qasem and colleagues at Alfaisal University in Riyadh, Batterjee Medical College in Jeddah and the University of Tennessee and Erlanger Hospital in Chattanooga, followed PRISMA reporting standards and searched PubMed, Scopus, Web of Science and Embase for studies published between 2000 and 2025. Two reviewers screened studies independently, and quality was assessed with the Newcastle-Ottawa Scale and the Joanna Briggs Institute checklist. Thirteen studies covering 1,036 patients met the criteria.
The procedures involved were not confined to bariatric surgery: oncologic and emergency gastrointestinal operations also featured. Vomiting was identified as the most common precipitating factor. The classical triad of confusion, ataxia and oculomotor dysfunction appeared in only a minority of patients, while most presented with atypical features such as cognitive deficits and polyneuropathy. Magnetic resonance imaging showed the characteristic changes in the thalami, mammillary bodies and periaqueductal gray in confirmed cases. Reported mortality varied widely between studies, from 0.3 percent in bariatric cohorts to 40 percent in patients having cancer surgery. Early intravenous thiamine was associated with favourable outcomes, though the authors note that dosing protocols differed considerably from study to study.
The stakes for families are that thiamine deficiency left untreated can leave a lasting amnestic disorder, Korsakoff syndrome, the chronic phase of Wernicke-Korsakoff syndrome. The American Society for Metabolic and Bariatric Surgery published task force guidelines on prevention, diagnosis and treatment of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome online on 10 April 2025, in Surgery for Obesity and Related Diseases, stating an aim of reducing the incidence of both. The Frontiers authors conclude that prophylactic thiamine supplementation should be strongly considered in high-risk patients, particularly those with malnutrition, prolonged fasting or persistent vomiting. That is a recommendation addressed to surgical and neurology teams, not a self-treatment instruction.
The counterpoint is the shape of the evidence. This is a narrative synthesis of thirteen heterogeneous studies, not a pooled analysis and not a trial, and the review reports no overall rate at which Wernicke encephalopathy follows gastrointestinal surgery, because the included studies do not share a common denominator. The wide mortality spread reflects different patient populations, not a like for like comparison, and the observation that early intravenous thiamine went with better outcomes comes from clinical reports rather than randomised allocation.